Improving opportunities for engagement for hospital inpatients with Huntington's Disease

Do Huntington's Disease inpatients in a subacute neurological ward who receive Diversional Therapy, compared to those you receive normal ward care, have an enhanced experience during their hospital admission?

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12610000994088

Enrollment

Registered

2010-11-16

Start date

2010-08-23

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to investigate how the introduction of a Diversional Therapist effects patients with Huntington's Disease, in an inpatient neurological setting. In particular we are interested in how these patients do or do not engage with other people and with activities.

Interventions

Ward-based Diversional Therapy program. A Diversional Therapist will be employed 6 hours/day for 4 days/week to provide individual and group Diversional Therapy sessions, for a period of 6 months.

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Patients with the diagnosis of Huntington's Disease admitted to the ward during the period of the study

Exclusion criteria

Patients (or their next of kin) who do not give consent to participate will be excluded from the study.

Outcome results